Delivery Order SPE2DB20D3103-SPE2DB25FM7Z5

Award Date 2/21/25
Potential Completion Date 2/24/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,195.67, is for the delivery of Junel Fe 1.5 mg-30 mcg tablets. The contract has a completion date of November 3, 2023 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,272.96 firm fixed price contract is for the supply of Junel Fe 1.5 mg-30 mcg tablet prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical that provides a wide range of pharmaceutical and medical supplies to support...
This is a $1,893.72 firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of JUNEL FE 1 MG-20 MCG TABLET 28S, a prescription pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.18 firm fixed-price contract is for the delivery of Junel FE 1 mg-20 mcg tablets, a contraceptive medication, to support military healthcare programs. The contract has a period of performance through February 3, 2025 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of pharmaceutical products. The contract has a ceiling value of $1,426.54 and is for the delivery of the drug product Junel FE 1 mg-20 mcg tablet in 28-count packages. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which has an ultimate completion date of October 7, 2024....
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,753,843 units of the pharmaceutical product Junel FE 1 mg-20 mcg tablets. The contract has a firm fixed price of $1,209.60 and a completion date of September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,117.00 firm fixed-price contract is for the supply of Junel FE 1 mg-20 mcg tablets, a pharmaceutical product. The contract has an ultimate completion date of April 20, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $9,356.74, is for the supply of 4,564,084,844 units of the pharmaceutical product Junel FE 1.5 mg-30 mcg tablet, packaged in 28-count containers. The contract is a firm fixed price arrangement with a period of performance running through March 27, 2024. Amerisourcebergen Drug Corporation is a prime contractor that...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug product "JUNEL FE 1.5 MG-30 MCG TABLET 28S". The contract has a ceiling value of $1,388.92 and an ultimate completion date of April 26, 2023. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor to the U.S. federal government. The contract, valued at $1,429.73, is for the supply of Junel Fe 1 mg-20 mcg tablet, a prescription birth control medication. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM7Z5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,008.36, is for the delivery of Junel FE 1.5 mg-30 mcg tablets in 28-count packages. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/23/25, 10:15 AM